Affymetrix, Inc. (NASDAQ:AFFX)
CAPS Rating:
Engaged in the development, manufacture, sale and service of consumables and systems for genetic analysis in the life sciences and clinical healthcare markets and create tools that advances the understanding of the molecular basis of life.
RSS Headlines
Fool UK
Recs
their genotyping platform will be adapted more widely for personalized medicine tests to determine likely efficacy of drugs, and before that, used to establish those markers in R&D